1-3 of 3
Amy D. Klion, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dexpramipexole As a Steroid-Sparing Agent in Hypereosinophilic Syndromes (HES): An Open-Label Proof-of-Concept Study

Sandhya R. Panch, MD MPH, Michael Bozik, MD, Thomas Brown, RN, Ulrike Demarco, Dipl. Biol., Jamie Hahn, BS, Alexander Komarov, PhD, Tamika Magee, RN, Michelle Makiya, RN, Calman Prussin, MD, Armando Signore, PhD, Mary Sullivan, BA, Lauren Wetzler, MHS, PA, Cynthia E. Dunbar, MD, Steven Dworetzky, PhD, Irina Maric, MD, Amy D Klion, MD
Journal: Blood
Blood (2016) 128 (22): 1327.
https://doi.org/10.1182/blood.V128.22.1327.1327
Published: 2016
Journal Articles

Safety and Tolerability of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Amy D. Klion, MD, Marc E. Rothenberg, MD, PhD, John J. Murray, MD,PhD, Anish Singh, MD, PhD, Hans-Uwe Simon, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2694.
https://doi.org/10.1182/blood.V108.11.2694.2694
Published: 2006
Journal Articles

Lineage Analysis of the FIPL1-PDGFRα Fusion Gene in Myeloproliferative Hypereosinophilic Syndrome.

Steven J. Lemery, MD, Jamie A. Robyn, MD/PhD, J. Philip McCoy, PhD, Joseph Kubofcik, BS, YaeJean Kim, MD, Thomas B. Nutman, MD, Cynthia E. Dunbar, MD, Amy D. Klion, MD
Journal: Blood
Blood (2004) 104 (11): 2441.
https://doi.org/10.1182/blood.V104.11.2441.2441
Published: 2004